Notices Relating to Transferred Approvals. TRIS will deliver a letter in the form of Exhibit 10.4(b) to the FDA for the NDA and IND included in the Transferred Registration, along with a Form 356h along with a Form 356h and an XML receipt from the FDA in respect of such letter.
Appears in 2 contracts
Sources: Settlement and Termination of License Agreement (Aytu Biopharma, Inc), Settlement and Termination of License Agreement (Aytu Biopharma, Inc)